• |
  • |
  • |
  • |
Donate

Product

A phase I/2 randomized double-blind placebo-controlled, single-dose dose escallation study of KB001 in CF patients infected with p. aeruginosa

Center:
Fiscal Year:
2009
Contact Information:
Product Description:
Keyword(s):
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A